Your browser doesn't support javascript.
loading
A novel computational predictive biological approach distinguishes Integrin ß1 as a salient biomarker for breast cancer chemoresistance.
Das, Subhayan; Kundu, Moumita; Hassan, Atif; Parekh, Aditya; Jena, Bikash Ch; Mundre, Swati; Banerjee, Indranil; Yetirajam, Rajesh; Das, Chandan K; Pradhan, Anjan K; Das, Swadesh K; Emdad, Luni; Mitra, Pralay; Fisher, Paul B; Mandal, Mahitosh.
Affiliation
  • Das S; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Kundu M; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Hassan A; Department of Computer Science & Engineering, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Parekh A; Anant National University, Ahmedabad, Gujarat, India.
  • Jena BC; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Mundre S; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Banerjee I; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India; School of Pharmacy, Sister Nivedita University (Techno India Group), Kolkata, West Bengal, India.
  • Yetirajam R; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Das CK; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Pradhan AK; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA.
  • Das SK; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; VCU Massey Cancer Center, Virginia Commonwealth University, School of Med
  • Emdad L; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; VCU Massey Cancer Center, Virginia Commonwealth University, School of Med
  • Mitra P; Department of Computer Science & Engineering, Indian Institute of Technology Kharagpur, Kharagpur, India.
  • Fisher PB; Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; VCU Massey Cancer Center, Virginia Commonwealth University, School of Med
  • Mandal M; School of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, India. Electronic address: mahitosh@smst.iitkgp.ac.in.
Biochim Biophys Acta Mol Basis Dis ; 1869(6): 166702, 2023 08.
Article in En | MEDLINE | ID: mdl-37044238
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Integrin beta1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2023 Document type: Article Affiliation country: India Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Integrin beta1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2023 Document type: Article Affiliation country: India Country of publication: Netherlands